Go to
current issue
-
del(8p) and TNFRSF10B loss are associated with a poor prognosis and resistance to fludarabine in chronic lymphocytic leukemia Leukemia (IF 11.4) Pub Date : 2023-09-26 Ludovic Jondreville, Lea Dehgane, Cecile Doualle, Luce Smagghe, Beatrice Grange, Frederic Davi, Leticia K. Lerner, Delphine Garnier, Clotilde Bravetti, Olivier Tournilhac, Damien Roos-Weil, Marouane Boubaya, Elise Chapiro, Santos A. Susin, Florence Nguyen-Khac
-
Combination of chemotherapy and all-trans retinoic acid for the treatment KMT2A-rearranged infant acute lymphoblastic leukemia. Results of the MLL-Baby trial Leukemia (IF 11.4) Pub Date : 2023-09-23 Larisa Fechina, Alexander Popov, Grigory Tsaur, Guenter Henze, Egor Shorikov, Olga Makarova, Olga Khlebnikova, Yulia Zhukova, Oleg Arakaev, Olga Streneva, Tatiana Verzhbitskaya, Tatiana Riger, Alexander Solodovnikov, Elena Lapotentova, Olga Aleinikova, Natalia Myakova, Elmira Boichenko, Konstantin Kondratchik, Olga Nikonova, Alexander Shapochnik, Marina Goroshkova, Natalia Ponomareva, Galina Novichkova
-
The acidic stretch and the C-terminal nuclear export signal motif of NPM1 mutant: are they druggable in AML? Leukemia (IF 11.4) Pub Date : 2023-09-22 Brunangelo Falini, Bjorn T. Gjertsen, Vibeke Andresen
-
Histone deacetylase inhibitors modulate hormesis in leukemic cells with mutant FMS-like tyrosine kinase-3 Leukemia (IF 11.4) Pub Date : 2023-09-21 Yanira Zeyn, Kristin Hausmann, Melisa Halilovic, Mandy Beyer, Hany S. Ibrahim, Walburgis Brenner, Siavosh Mahboobi, Matthias Bros, Wolfgang Sippl, Oliver H. Krämer
-
Efficacy and safety of bemcentinib in patients with advanced myelodysplastic neoplasms or acute myeloid leukemia failing hypomethylating agents- the EMSCO phase II BERGAMO trial Leukemia (IF 11.4) Pub Date : 2023-09-21 A. S. Kubasch, P. Peterlin, T. Cluzeau, K. S. Götze, K. Sockel, R. Teipel, M. Jentzsch, H. Attalah, M. Sebert, F. Chermat, S. Gloaguen, M. Puttrich, M. Cross, M. Schneider, S. Kayser, D. Schipp, A. Giagounidis, I. Tirado-Gonzalez, A. Descot, A. van de Loosdrecht, A. Weigert, K. H. Metzeler, P. Fenaux, H. Medyouf, U. Platzbecker, L. Ades
-
Clinical phenotypes, molecular analysis, and outcomes of patients with Rosai-Dorfman disease Leukemia (IF 11.4) Pub Date : 2023-09-20 Long Chang, Bing Qiao, Hao Cai, He Lin, Ming-hui Duan, Jian Li, Dao-bin Zhou, Gaurav Goyal, Chun-yan Sun, Xin-xin Cao
-
Survival with chronic myeloid leukaemia after failing milestones Leukemia (IF 11.4) Pub Date : 2023-09-19 Michael Lauseker, Rüdiger Hehlmann, Andreas Hochhaus, Susanne Saußele
-
Correction: Human CD34+ very small embryonic-like stem cells can give rise to endothelial colony-forming cells with a multistep differentiation strategy using UM171 and nicotinamide acid Leukemia (IF 11.4) Pub Date : 2023-09-18 Alison Domingues, Elisa Rossi, Kamila Bujko, Grégoire Detriche, Ulysse Richez, Adeline Blandinieres, Magdalena Kucia, Janina Ratajczak, David M. Smadja, Mariusz Z. Ratajczak
-
Identification of novel genetic loci for risk of multiple myeloma by functional annotation Leukemia (IF 11.4) Pub Date : 2023-09-18 Angelica Macauda, Klara Briem, Alyssa Clay-Gilmour, Wendy Cozen, Asta Försti, Matteo Giaccherini, Chiara Corradi, Juan Sainz, Yasmeen Niazi, Rob ter Horst, Yang Li, Mihai G. Netea, Ulla Vogel, Kari Hemminki, Susan L. Slager, Judit Varkonyi, Vibeke Andersen, Elzbieta Iskierka-Jazdzewska, Joaquin Mártinez-Lopez, Jan Zaucha, Nicola J. Camp, S. Vincent Rajkumar, Agnieszka Druzd-Sitek, Parveen Bhatti, Stephen
-
Persistence of ex vivo expanded tumour and pathogen specific T-cells after allogeneic stem cell transplant for myeloid malignancies (the INTACT study) Leukemia (IF 11.4) Pub Date : 2023-09-15 Wei Jiang, Selmir Avdic, Koon H. Lee, Janine Street, Gloria Castellano-González, Renee Simms, Leighton E. Clancy, Richard Blennerhassett, Ellis Patrick, Adam S. Chan, Helen M. McGuire, Nadav Myers, Brian S. Gloss, Melissa Gabriel, Caroline M. Bateman, Ken Micklethwaite, David J. Gottlieb, Emily Blyth
-
A novel gene fusion RUNX1/ZNF423 promotes leukemic relapse of NUP98-rearranged AML Leukemia (IF 11.4) Pub Date : 2023-09-15 Wenxin Du, Zhimei Xia, Zebin Luo, Yichang Chen, Shaowei Bing, Wei Wang, Xingya Zhang, Zhan Zhou, Jingying Zhang, Ji Cao, Bo Yang, Qiaojun He, Xuejing Shao, Xiaojun Xu, Meidan Ying
-
Ppm1d truncating mutations promote the development of genotoxic stress-induced AML Leukemia (IF 11.4) Pub Date : 2023-09-14 Monika Burocziova, Petr Danek, Anna Oravetzova, Zuzana Chalupova, Meritxell Alberich-Jorda, Libor Macurek
-
Have we been qualifying measurable residual disease correctly? Leukemia (IF 11.4) Pub Date : 2023-09-13 Yahui Feng, Saibing Qi, Xueou Liu, Li Zhang, Yu Hu, Qiujin Shen, Xiaowen Gong, Wei Zhang, Junxia Wang, Wen Yan, Tiantian Wang, Huijun Wang, Zhen Song, Xiaofan Zhu, Robert Peter Gale, Junren Chen
-
CD7 targeted “off-the-shelf” CAR-T demonstrates robust in vivo expansion and high efficacy in the treatment of patients with relapsed and refractory T cell malignancies Leukemia (IF 11.4) Pub Date : 2023-09-12 Shiqi Li, Xinxin Wang, Lin Liu, Jia Liu, Jun Rao, Zhongtao Yuan, Li Gao, Yu Li, Le Luo, Gui Li, Zhimin Li, Sheng Li, Jiaping He, Lihua Zhang, Lvzhe Chen, Wenhui Huang, Ping Yin, Chunmin Li, Xiaoping Li, Youcheng Wang, Yancheng Dong, Dingsong Zhang, Qingying Zang, Yingnian Chen, Lianjun Shen, Wenling Li, Wei Cao, Xi Zhang, Sanbin Wang
-
Identification of DHX40 as a candidate susceptibility gene for colorectal and hematological neoplasia Leukemia (IF 11.4) Pub Date : 2023-09-11 Alisa Olkinuora, Taina T. Nieminen, Suvi Douglas, Anni Kauppinen, Mika Kontro, Juho Väänänen, Matti Kankainen, Ari Ristimäki, Markus Mäkinen, Päivi Lahermo, Caroline Heckman, Janna Saarela, Milla Salonen, Anna Lepistö, Heikki Järvinen, Jukka-Pekka Mecklin, Outi Kilpivaara, Ulla Wartiovaara-Kautto, Kimmo Porkka, Päivi Peltomäki
-
FBXO21 mediated degradation of p85α regulates proliferation and survival of acute myeloid leukemia Leukemia (IF 11.4) Pub Date : 2023-09-09 Kasidy K. Dobish, Karli J. Wittorf, Samantha A. Swenson, Dalton C. Bean, Catherine M. Gavile, Nicholas T. Woods, Gargi Ghosal, R. Katherine Hyde, Shannon M. Buckley
-
Infection risk associated with clonal hematopoiesis of indeterminate potential is partly mediated by hematologic cancer transformation in the UK Biobank Leukemia (IF 11.4) Pub Date : 2023-09-09 Caitlyn Vlasschaert, Elvis Akwo, Cassianne Robinson-Cohen, Elina K. Cook, Matthew B. Lanktree, Michael J. Rauh, Alexander G. Bick
-
Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia – implications for the European leukemia net risk classification Leukemia (IF 11.4) Pub Date : 2023-09-07 Jan-Niklas Eckardt, Marius Bill, Christian Rausch, Klaus Metzeler, Karsten Spiekermann, Sebastian Stasik, Tim Sauer, Sebastian Scholl, Andreas Hochhaus, Martina Crysandt, Tim H. Brümmendorf, Utz Krug, Bernhard Wörmann, Wolfgang Hiddemann, Dennis Görlich, Cristina Sauerland, Björn Steffen, Hermann Einsele, Andreas Neubauer, Andreas Burchert, Kerstin Schäfer-Eckart, Wolfgang E. Berdel, Christoph Schliemann
-
BRAFV600E promotes DC3/monocyte differentiation in human gene-engineered HSPCs and causes multisystem histiocytosis Leukemia (IF 11.4) Pub Date : 2023-09-06 Tommaso Sconocchia, Johannes Foßelteder, Lisa Auinger, Erdem Özkaya, Theresa Benezeder, Magdalena Lang, Christine Beham-Schmid, Gerald Hoefler, Armin Zebisch, Albert Wölfler, Heinz Sill, Peter Wolf, Herbert Strobl, Andreas Reinisch
-
CAR virus receptor mediates erythroid differentiation and migration and is downregulated in MDS Leukemia (IF 11.4) Pub Date : 2023-09-06 Karin Bauer, Sigrid Machherndl-Spandl, Lukas Kazianka, Irina Sadovnik, Sinan Gültekin, Susanne Suessner, Johannes Proell, Jeroen Lauf, Gregor Hoermann, Gregor Eisenwort, Norman Häfner, Mathilde Födermayr-Mayrleitner, Ann-Sofie Schmolke, Emiel van der Kouwe, Uwe Platzbecker, Thomas Lion, Ansgar Weltermann, Otto Zach, Gerald Webersinke, Ulrich Germing, Christian Gabriel, Wolfgang R. Sperr, Marie C. Béné
-
MiR-9-1 controls osteoblastic regulation of lymphopoiesis Leukemia (IF 11.4) Pub Date : 2023-09-05 Yongguang Zhang, Danfeng Lin, Yongwei Zheng, Yuhong Chen, Mei Yu, Dongya Cui, Miaohui Huang, Xinlin Su, Yong Sun, Yabing Chen, Zhijian Qian, Karen-Sue Carlson, Renren Wen, Demin Wang
-
Frequent ZNF217 mutations lead to transcriptional deregulation of interferon signal transduction via altered chromatin accessibility in B cell lymphoma Leukemia (IF 11.4) Pub Date : 2023-08-30 Franziska Briest, Daniel Noerenberg, Cornelius Hennch, Kenichi Yoshida, Raphael Hablesreiter, Jose Nimo, Daniel Sasca, Marieluise Kirchner, Larry Mansouri, Yoshikage Inoue, Laura Wiegand, Annette M. Staiger, Beatrice Casadei, Penelope Korkolopoulou, January Weiner, Armando Lopez-Guillermo, Arne Warth, Tamás Schneider, Ákos Nagy, Wolfram Klapper, Michael Hummel, George Kanellis, Ioannis Anagnostopoulos
-
miR-126 identifies a quiescent and chemo-resistant human B-ALL cell subset that correlates with minimal residual disease Leukemia (IF 11.4) Pub Date : 2023-08-28 Carolina Caserta, Silvia Nucera, Matteo Barcella, Grazia Fazio, Matteo Maria Naldini, Riccardo Pagani, Francesca Pavesi, Giacomo Desantis, Erika Zonari, Mariella D’Angiò, Paola Capasso, Angelo Lombardo, Ivan Merelli, Orietta Spinelli, Alessandro Rambaldi, Fabio Ciceri, Daniela Silvestri, Maria Grazia Valsecchi, Andrea Biondi, Giovanni Cazzaniga, Bernhard Gentner
-
Event-free survival in patients with polycythemia vera treated with ropeginterferon alfa-2b versus best available treatment Leukemia (IF 11.4) Pub Date : 2023-08-26 Heinz Gisslinger, Christoph Klade, Pencho Georgiev, Dorota Krochmalczyk, Liana Gercheva-Kyuchukova, Miklos Egyed, Petr Dulicek, Arpad Illes, Halyna Pylypenko, Lylia Sivcheva, Jiří Mayer, Vera Yablokova, Kurt Krejcy, Victoria Empson, Hans C. Hasselbalch, Robert Kralovics, Jean-Jacques Kiladjian
-
Genomics of deletion 7 and 7q in myeloid neoplasm: from pathogenic culprits to potential synthetic lethal therapeutic targets Leukemia (IF 11.4) Pub Date : 2023-08-26 Minako Mori, Yasuo Kubota, Arda Durmaz, Carmelo Gurnari, Charnise Goodings, Vera Adema, Ben Ponvilawan, Waled S. Bahaj, Tariq Kewan, Thomas LaFramboise, Manja Meggendorfer, Claudia Haferlach, John Barnard, Marcin Wlodarski, Valeria Visconte, Torsten Haferlach, Jaroslaw P. Maciejewski
-
Preclinical development of 1B7/CD3, a novel anti-TSLPR bispecific antibody that targets CRLF2-rearranged Ph-like B-ALL Leukemia (IF 11.4) Pub Date : 2023-08-26 Ze Tian, Chunhua Shi, Guojun Yang, Jason K. Allen, Qing Shi, Amin AI-Shami, Jill Wardell Olson, Melinda G. Smith, Qing Chang, Jasbir Kaur, Junping You, Timothy E. Lofton, Michelle A. Gonzalez, Qi Zhang, DongXing Zha, Sarah K. Tasian, Nitin Jain, Marina Y. Konopleva, Timothy Heffernan, Jeffrey J. Molldrem
-
How should we interpret conclusions of TKI-stopping studies Leukemia (IF 11.4) Pub Date : 2023-08-25 Robert Peter Gale, Junren Chen
-
Who wins the combat, CAR or TCR? Leukemia (IF 11.4) Pub Date : 2023-08-25 Kun Yun, Elizabeth L. Siegler, Saad S. Kenderian
-
Glasdegib plus intensive or non-intensive chemotherapy for untreated acute myeloid leukemia: results from the randomized, phase 3 BRIGHT AML 1019 trial Leukemia (IF 11.4) Pub Date : 2023-08-21 Mikkael A. Sekeres, Pau Montesinos, Jan Novak, Jianxiang Wang, Deepa Jeyakumar, Benjamin Tomlinson, Jiri Mayer, Erin Jou, Tadeusz Robak, David C. Taussig, Hervé Dombret, Akil Merchant, Naveed Shaik, Thomas O’Brien, Whijae Roh, Xueli Liu, Wendy Ma, Christine G. DiRienzo, Geoffrey Chan, Jorge E. Cortes
-
Exploiting the fibroblast growth factor receptor-1 vulnerability to therapeutically restrict the MYC-EZH2-CDKN1C axis-driven proliferation in Mantle cell lymphoma Leukemia (IF 11.4) Pub Date : 2023-08-19 Anuvrat Sircar, Satishkumar Singh, Zijun Y. Xu-Monette, Krysta Mila Coyle, Laura K. Hilton, Evangelia Chavdoula, Parvathi Ranganathan, Neeraj Jain, Walter Hanel, Philip Tsichlis, Lapo Alinari, Blake R. Peterson, Jianguo Tao, Natarajan Muthusamy, Robert Baiocchi, Narendranath Epperla, Ken H. Young, Ryan Morin, Lalit Sehgal
-
Clinical impact of the genomic landscape and leukemogenic trajectories in non-intensively treated elderly acute myeloid leukemia patients Leukemia (IF 11.4) Pub Date : 2023-08-17 Ekaterina Jahn, Maral Saadati, Pierre Fenaux, Marco Gobbi, Gail J. Roboz, Lars Bullinger, Pavlo Lutsik, Anna Riedel, Christoph Plass, Nikolaus Jahn, Claudia Walter, Karlheinz Holzmann, Yong Hao, Sue Naim, Nicholas Schreck, Julia Krzykalla, Axel Benner, Harold N. Keer, Mohammad Azab, Konstanze Döhner, Hartmut Döhner
-
Myelodysplastic neoplasm-associated U2AF1 mutations induce host defense defects by compromising neutrophil chemotaxis Leukemia (IF 11.4) Pub Date : 2023-08-17 Natalia J. Gurule, Kenneth C. Malcolm, Chelsea Harris, Jennifer R. Knapp, Brian P. O’Connor, Jazalle McClendon, William J. Janssen, Frank Fang Yao Lee, Caitlin Price, Jackson Osaghae-Nosa, Emily A. Wheeler, Christine M. McMahon, Eric M. Pietras, Daniel A. Pollyea, Scott Alper
-
TAL1 hijacks MYCN enhancer that induces MYCN expression and dependence on mevalonate pathway in T-cell acute lymphoblastic leukemia Leukemia (IF 11.4) Pub Date : 2023-08-17 Shi Hao Tan, Tze King Tan, Rui Yokomori, Minghui Liao, Xiao Zi Huang, Allen Eng Juh Yeoh, Takaomi Sanda
-
S1P-S1PR3-RAS promotes the progression of S1PR3hi TAL1+ T-cell acute lymphoblastic leukemia that can be effectively inhibited by an S1PR3 antagonist Leukemia (IF 11.4) Pub Date : 2023-08-17 Dan Zhu, Tingting Jiang, Deyu Ma, Hongyang Zhang, Jia Zhang, Wenqiong Lv, Maoyuan Gong, Haobiao Wang, Ziyang Liu, Hongyu Su, Lamei Zeng, Shan Liu, Shi Tang, Bijie Yang, Filippus I. Tshavuka, Guo Fu, Zidai Liu, Danyi Peng, Haiyan Liu, Zijun Yan, Ziyang Cao, Hui Zhao, Tong-Chuan He, Jie Yu, Yi Shu, Lin Zou
-
Cell fate determinant Llgl1 is required for propagation of acute myeloid leukemia Leukemia (IF 11.4) Pub Date : 2023-08-16 Theresa Eifert, Chen-Jen Hsu, Alicia L. Becker, Sarah Graessle, Arik Horne, Franziska Bemmann, Qirui Zhang, Michael Heuser, Valeri Vasioukhin, Sebastian Scholl, Andreas Hochhaus, Florian Siegerist, Nicole Endlich, Lars Bullinger, Steven W. Lane, Simon Haas, Tina M. Schnoeder, Florian H. Heidel
-
Perspectives on acute myeloid leukemia diagnosis: a comparative analysis of the latest World Health Organization and the International Consensus Classifications Leukemia (IF 11.4) Pub Date : 2023-08-14 Jin Jung, Daehun Kwag, Yonggoo Kim, Jong-Mi Lee, Ari Ahn, Hoon Seok Kim, Byunggyu Bae, Silvia Park, Hee-Je Kim, Byung-Sik Cho, Myungshin Kim
-
Risk assessment according to IPSS-M is superior to AML ELN risk classification in MDS/AML overlap patients defined by ICC Leukemia (IF 11.4) Pub Date : 2023-08-12 Sandra Huber, Constance Baer, Stephan Hutter, Frank Dicker, Irene Fuhrmann, Manja Meggendorfer, Christian Pohlkamp, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach, Gregor Hoermann
-
CD6-targeted antibody-drug conjugate as a new therapeutic agent for T cell lymphoma Leukemia (IF 11.4) Pub Date : 2023-08-12 Neetha Parameswaran, Liping Luo, Lingjun Zhang, Joel Chen, Frank P. DiFilippo, Charlie Androjna, David A. Fox, Sarah L. Ondrejka, Eric D. Hsi, Deepa Jagadeesh, Daniel J. Lindner, Feng Lin
-
Intensifying treatment in PET-positive multiple myeloma patients after upfront autologous stem cell transplantation Leukemia (IF 11.4) Pub Date : 2023-08-11 Jakob Nordberg Nørgaard, Niels Abildgaard, Anna Lysén, Galina Tsykunova, Annette Juul Vangsted, Cristina João, Nora Remen, Lene Kongsgaard Nielsen, Liv Osnes, Caroline Stokke, James P. Connelly, Mona-Elisabeth R. Revheim, Fredrik Schjesvold
-
Novel insights into the pathogenesis of follicular lymphoma by molecular profiling of localized and systemic disease forms Leukemia (IF 11.4) Pub Date : 2023-08-10 Sabrina Kalmbach, Michael Grau, Myroslav Zapukhlyak, Ellen Leich, Vindi Jurinovic, Eva Hoster, Annette M. Staiger, Katrin S. Kurz, Oliver Weigert, Erik Gaitzsch, Verena Passerini, Marianne Engelhard, Klaus Herfarth, Klaus Beiske, Francesca Micci, Peter Möller, Heinz-Wolfram Bernd, Alfred C. Feller, Wolfram Klapper, Harald Stein, Martin-Leo Hansmann, Sylvia Hartmann, Martin Dreyling, Harald Holte, Georg
-
FLT3 inhibitors as MRD-guided salvage treatment for molecular failure in FLT3 mutated AML Leukemia (IF 11.4) Pub Date : 2023-08-09 Jad Othman, Nicola Potter, Katya Mokretar, David Taussig, Anjum Khan, Pramila Krishnamurthy, Anne-Louise Latif, Paul Cahalin, James Aries, Mariam Amer, Edward Belsham, Eibhlin Conneally, Charles Craddock, Dominic Culligan, Mike Dennis, Caroline Duncan, Sylvie D. Freeman, Caroline Furness, Amanda Gilkes, Paraskevi Gkreka, Katherine Hodgson, Wendy Ingram, Manish Jain, Andrew King, Steven Knapper, Panagiotis
-
A novel germline PAX5 single exon deletion in a pediatric patient with precursor B-cell leukemia Leukemia (IF 11.4) Pub Date : 2023-08-05 N. van Engelen, M. Roest, F. van Dijk, E. Sonneveld, R. Bladergroen, S. V. van Reijmersdal, V. H. J. van der Velden, P. G. Hoogeveen, W. A. Kors, E. Waanders, M. C. J. Jongmans, R. P. Kuiper
-
Rituximab administration in pediatric patients with newly diagnosed acute lymphoblastic leukemia Leukemia (IF 11.4) Pub Date : 2023-08-05 Keito Hoshitsuki, Yinmei Zhou, April M. Miller, John K. Choi, Hope D. Swanson, Nickhill H. Bhakta, Sima Jeha, Seth E. Karol, Raul C. Ribeiro, Jeffrey E. Rubnitz, Charles G. Mullighan, Cheng Cheng, Jun J. Yang, Mary V. Relling, Ching-Hon Pui, Hiroto Inaba
-
Skin lesions, arthritis, chondritis, and cytopenias Leukemia (IF 11.4) Pub Date : 2023-08-04 Edwin U. Suárez, Elena Prieto, Miguel Ángel González-Gay, Carlos Soto, Carlos Blas, Luis Requena-Caballero
-
EZH2 targeting induces CD38 upregulation and response to anti-CD38 immunotherapies in multiple myeloma Leukemia (IF 11.4) Pub Date : 2023-08-02 Djamila Chemlal, Emmanuel Varlet, Amelie Machura, Sara Ovejero, Guilhem Requirand, Nicolas Robert, Guillaume Cartron, Elina Alaterre, Caroline Bret, Laure Vincent, Charles Herbaux, Giacomo Cavalli, Angélique Bruyer, Hugues De Boussac, Jerome Moreaux
-
Kinase-independent role of mTOR and on-/off-target effects of an mTOR kinase inhibitor Leukemia (IF 11.4) Pub Date : 2023-08-02 Cuiqing Fan, Mark Wunderlich, Xiongwei Cai, Zijun Yan, Feng Zhang, Ashley Kuenzi Davis, Lingli Xu, Fukun Guo, Q. Richard Lu, Mohammad Azam, Weidong Tian, Yi Zheng
-
A C/ebpα isoform specific differentiation program in immortalized myelocytes Leukemia (IF 11.4) Pub Date : 2023-08-02 Maria-Paz Garcia-Cuellar, Selin Akan, Robert K. Slany
-
XPO1 inhibition sensitises CLL cells to NK cell mediated cytotoxicity and overcomes HLA-E expression Leukemia (IF 11.4) Pub Date : 2023-08-01 Jack G. Fisher, Amber D. P. Doyle, Lara V. Graham, Shreyanshi Sonar, Ben Sale, Isla Henderson, Luis Del Rio, Peter W. M. Johnson, Yosef Landesman, Mark S. Cragg, Francesco Forconi, Christopher J. Walker, Salim. I. Khakoo, Matthew D. Blunt
-
Comparison between measurable residual disease relapse and morphologic relapse in acute myeloid leukemia and high-grade myeloid neoplasms Leukemia (IF 11.4) Pub Date : 2023-07-31 Lauren Shih, Megan Othus, Kelda Schonhoff, Carole Shaw, Jacob Appelbaum, Anna B. Halpern, Pamela S. Becker, Roland B. Walter, Elihu Estey, Mary-Elizabeth Percival
-
Prognostic impact of secondary versus de novo ontogeny in acute myeloid leukemia is accounted for by the European LeukemiaNet 2022 risk classification Leukemia (IF 11.4) Pub Date : 2023-07-31 Michael J. Hochman, Megan Othus, Robert P. Hasserjian, Alex Ambinder, Andrew Brunner, Mary-Elizabeth M. Percival, Christopher S. Hourigan, Ronan Swords, Amy E. DeZern, Elihu H. Estey, Judith E. Karp
-
External validation of the predictive scoring systems for molecular responses in chronic myeloid leukaemia receiving initial imatinib-therapy Leukemia (IF 11.4) Pub Date : 2023-07-29 Feiyang Qi, Xiaoshuai Zhang, Robert Peter Gale, Bingcheng Liu, Jian Huang, Xiaojun Huang, Qian Jiang
-
WT1 and PRAME RNA-loaded dendritic cell vaccine as maintenance therapy in de novo AML after intensive induction chemotherapy Leukemia (IF 11.4) Pub Date : 2023-07-28 Yngvar Fløisand, Mats Remberger, Iris Bigalke, Dag Josefsen, Helen Vålerhaugen, Else Marit Inderberg, Richard W. Olaussen, Bjørn Tore Gjertsen, Rene Goedkoop, Christiane Geiger, Petra U. Prinz, Frauke M. Schnorfeil, Kai Pinkernell, Dolores J. Schendel, Gunnar Kvalheim
-
The JAK1/2 inhibitor ruxolitinib in patients with COVID-19 triggered hyperinflammation: the RuxCoFlam trial Leukemia (IF 11.4) Pub Date : 2023-07-28 J. Hammersen, S. Birndt, K. Döhner, P. Reuken, A. Stallmach, P. Sauerbrey, F. La Rosée, M. Pfirrmann, C. Fabisch, M. Weiss, K. Träger, H. Bremer, S. Russo, G. Illerhaus, D. Drömann, S. Schneider, P. La Rosée, A. Hochhaus
-
Clinical outcome of Mantle Cell Lymphoma patients with high-risk disease (high-risk MIPI-c or high p53 expression) Leukemia (IF 11.4) Pub Date : 2023-07-26 Gabriel Scheubeck, Linmiao Jiang, Olivier Hermine, Hanneke C. Kluin-Nelemans, Christian Schmidt, Michael Unterhalt, Andreas Rosenwald, Wolfram Klapper, Andrea Evangelista, Marco Ladetto, Mats Jerkeman, Simone Ferrero, Martin Dreyling, Eva Hoster
-
Perturbed epigenetic transcriptional regulation in AML with IDH mutations causes increased susceptibility to NK cells Leukemia (IF 11.4) Pub Date : 2023-07-26 Anna Palau, Filip Segerberg, Michael Lidschreiber, Katja Lidschreiber, Aonghus J. Naughton, Maria Needhamsen, Lisa Anna Jung, Maja Jagodic, Patrick Cramer, Sören Lehmann, Mattias Carlsten, Andreas Lennartsson
-
Genetic and chemical targeting of the ATPase complex TIP48 and 49 impairs acute myeloid leukemia Leukemia (IF 11.4) Pub Date : 2023-07-25 Ayuna Hattori, Emi Takamatsu-Ichihara, Yoshiki Yamamoto, Shuhei Fujita, Kazutsune Yamagata, Takuo Katsumoto, Yukino Machida, Haruka Shinohara, Ryo Murakami, Issay Kitabayashi
-
Prognosis of IGLV3-21R110 chronic lymphocytic leukemia after chemotherapy-based treatment in a real-world analysis Leukemia (IF 11.4) Pub Date : 2023-07-21 Paul J. Hengeveld, Hendrik Veelken, Cornelis A. M. van Bergen, Edwin Quinten, Mischa Y. L. Vervoordeldonk, Wahija Ismailzada, Rob S. Barendse, Julie M. N. Dubois, Marinus H. J. van Oers, Christian H. Geisler, Arnon P. Kater, Peter E. Westerweel, Anton W. Langerak, Mark-David Levin
-
Are haematopoietic stem cell transplants stem cell transplants, is there a threshold dose of CD34-positive cells and how many are needed for rapid posttransplant granulocyte recovery? Leukemia (IF 11.4) Pub Date : 2023-07-20 Junren Chen, Robert Peter Gale, Yahui Feng, Yu Hu, Saibing Qi, Xueou Liu, Huaiping Zhu, Xiaowen Gong, Wei Zhang, Huilan Liu, Zimin Sun
-
Pharmacological inhibition of METTL3 impacts specific haematopoietic lineages Leukemia (IF 11.4) Pub Date : 2023-07-19 Katherine Sturgess, Eliza Yankova, M. S. Vijayabaskar, Tomoya Isobe, Justyna Rak, Iwo Kucinski, Melania Barile, Natalie A. Webster, Maria Eleftheriou, Rebecca Hannah, Malgorzata Gozdecka, George Vassiliou, Oliver Rausch, Nicola K. Wilson, Berthold Göttgens, Konstantinos Tzelepis
-
SETBP1 is dispensable for normal and malignant hematopoiesis Leukemia (IF 11.4) Pub Date : 2023-07-18 Atsushi Tanaka, Koutarou Nishimura, Wataru Saika, Ayana Kon, Yui Koike, Hiromi Tatsumi, June Takeda, Masaki Nomura, Weijia Zang, Manabu Nakayama, Masashi Matsuda, Hiromi Yamazaki, Miki Fukumoto, Hiromi Ito, Yasutaka Hayashi, Toshio Kitamura, Hiroshi Kawamoto, Akifumi Takaori-Kondo, Haruhiko Koseki, Seishi Ogawa, Daichi Inoue
更新日期：2023-09-22
Copyright © 2014-2023 北京衮雪科技有限公司 All Rights Reserved
京ICP备11026495-2号
京公网安备 11010802027423号
京公网安备 11010802027423号